• FOXO3 Regulates Dual Metabolic Pathways in Hepatocellular Ca

  2026-05-25

  This study uncovers how FOXO3 acts as a tumor suppressor in hepatocellular carcinoma (HCC) by simultaneously inhibiting glycolysis and glutaminolysis through direct repression of YAP transcription. The findings highlight dual metabolic targeting as a promising strategy for HCC therapy and clarify FOXO3's mechanistic role in metabolic reprogramming.

• Metabolomics Biomarkers Reveal Carbapenemase Resistance in E

  2026-05-24

  This study applies LC-MS/MS metabolomics to differentiate carbapenemase-producing Enterobacterales (CPE) from non-CPE strains using a panel of 21 metabolic biomarkers. The findings enable rapid, mechanism-based detection of resistance and offer new insight into the metabolic adaptations underlying CPE phenotypes.

• Methicillin Sodium Salt: Precision Tools for MSSA Research

  2026-05-23

  Methicillin sodium salt empowers researchers to model and differentiate MSSA versus MRSA infections with high reproducibility. This guide details optimized workflows, troubleshooting, and the unique mechanistic edge of APExBIO's product for advanced Staphylococcus aureus research.

• CircRHOBTB3 Restricts Prostate Cancer Growth via NONO-MAOA A

  2026-05-22

  The reference study identifies circRHOBTB3 as a tumor-suppressive circRNA in prostate cancer, demonstrating its ability to inhibit proliferation and metastasis by sequestering NONO in the cytoplasm and downregulating MAOA expression. These findings highlight circRHOBTB3 as a promising biomarker and potential therapeutic target in metastatic prostate cancer.

• Nonivamide: Capsaicin Analog for Precision Cancer & TRPV1 Re

  2026-05-22

  Nonivamide, a potent capsaicin analog, unlocks selective TRPV1 receptor targeting for apoptosis induction and tumor growth inhibition in advanced cancer and neuroimmune research. This article translates mechanistic insight and recent breakthroughs into actionable workflows, troubleshooting guidance, and protocol optimizations for researchers leveraging APExBIO's high-purity Nonivamide.

• MRSA: Mechanisms, Epidemiology, and Implications for Researc

  2026-05-21

  This review synthesizes foundational and clinical research on methicillin-resistant Staphylococcus aureus (MRSA), detailing the genetic, epidemiological, and therapeutic factors that shape its ongoing clinical threat. Key insights into resistance evolution, strain diversity, and implications for laboratory modeling inform robust design of MSSA/MRSA infection studies.

• Paeoniflorigenone Targets HIF1A to Inhibit Cholangiocarcinom

  2026-05-21

  This study demonstrates that paeoniflorigenone (PFG), a component derived from Moutan cortex, suppresses cholangiocarcinoma cell proliferation and enhances cisplatin sensitivity by modulating the HIF1A pathway. These findings offer new mechanistic insight and potential therapeutic strategies for overcoming chemoresistance in cholangiocarcinoma.

• 2-Hydroxypropyl-β-cyclodextrin: Practical Guide for Solubili

  2026-05-20

  2-Hydroxypropyl-β-cyclodextrin addresses solubility challenges in pharmaceutical and biochemical research workflows by forming inclusion complexes with hydrophobic compounds, particularly those containing aromatic or phenyl groups. Use is recommended strictly as a drug formulation excipient or for solubility improvement; broader or therapeutic applications are not supported by current product documentation.

• AM251 in Translational Neuroscience: Mechanisms and Strategi

  2026-05-20

  This thought-leadership article explores how AM251, a potent and selective CB1 receptor antagonist, is revolutionizing cannabinoid receptor research and translational neuroscience. We dissect the mechanistic nuances of AM251’s action, review experimental and workflow protocols, examine its role in the evolving therapeutic landscape, and provide strategic insights for researchers leveraging this tool in metabolic and neural studies. Integrating recent findings on endocannabinoid modulation in pain and affective disorders, this piece expands far beyond standard product literature to bridge workflows, clinical relevance, and future directions.

• BIBR 1532 (SKU A1945): Enhancing Telomerase Inhibition Workf

  2026-05-19

  This article addresses common experimental challenges in telomerase activity, cell viability, and apoptosis assays, illustrating how BIBR 1532 (SKU A1945) delivers reproducible and data-driven solutions. Scenario-based Q&A blocks offer actionable guidance for biomedical researchers and lab technicians, grounded in peer-reviewed evidence and real laboratory workflows.

• TaqI Restriction Endonuclease: Fast DNA Cleavage Protocols

  2026-05-19

  The TaqI Restriction Endonuclease (SKU K3053) provides a rapid, reliable solution for the specific digestion of plasmid, PCR, or genomic DNA, expediting workflows where time efficiency and accurate sticky end generation are critical. This enzyme is best suited for molecular biology research applications and should not be used for diagnostic or medical purposes.

• Gepotidacin in Antibacterial Research: Mechanisms, Metrics,

  2026-05-18

  Explore Gepotidacin's (GSK2140944) advanced mechanism as a bacterial DNA gyrase inhibitor and its transformative role in antibiotic resistance research. This article delivers strategic protocol guidance, key clinical insights, and expert analysis beyond assay troubleshooting.

• Imatinib (STI571) in Signal Transduction & Cancer Research

  2026-05-18

  Imatinib (STI571) revolutionizes kinase pathway studies with selective inhibition of Abl, c-Kit, and PDGF receptor kinases, enabling robust signal transduction and cancer biology research. This article delivers stepwise protocols, advanced synergy insights, and troubleshooting strategies tailored for reproducibility and translational impact.

• Advancing Plant Protein Stability: Mechanisms and Strategy

  2026-05-17

  Explore the mechanistic and translational rationale for robust protein stabilization in plant cell research. This thought-leadership article connects emerging mechanistic insights—including m6A-mediated plant-virus interactions—to actionable workflow optimization, with a focus on the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO. Learn how multidimensional protein degradation inhibition underpins reproducibility and innovation in plant molecular studies.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Advanced Immune Modulation

  2026-05-16

  Leverage the stability and translational efficiency of EZ Cap™ Mouse IL-12 mRNA (m1Ψ) for precision immunotherapy research and gene expression studies. Discover protocol enhancements, troubleshooting strategies, and the latest biomimetic delivery innovations for maximizing cytokine expression in extrahepatic tissues.

421 records 15/29 page Previous Next First page 上5页 1112131415 下5页 Last page